Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1
New England Journal of Medicine · 2025
DOI: 10.1056/nejmoa2407376 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Claire Booth und 30 weiteren Autor:innen. Beteiligte Einrichtung: University College London Great Ormond Street Institute of Child Health, London. Hauptthemen laut MEDLINE: CD18 Antigens, Genetic Therapy, Lentivirus, Leukocyte-Adhesion Deficiency Syndrome. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: California Institute for Regenerative Medicine, Rocket Pharmaceuticals, Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University College London Great Ormond Street Institute of Child Health, London.
- Great Ormond Street Hospital NHS Foundation Trust, London.
- Hematología y Hemoterapia, Fundación para la investigación Biomédica, Hospital Infantil Universitario Niño Jesús (HIUNJ), Madrid.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII), Madrid.
- Rocket Pharmaceuticals, Cranbury, NJ.
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Madrid.
ORCID-Profile: Julián Sevilla
Förderung
- California Institute for Regenerative Medicine
- Rocket Pharmaceuticals, Inc.
Zitieren
APA
Booth, C., Sevilla, J., Almarza, E., Kuo, C. Y., Zubicaray, J., Terrazas, D., O'Toole, G., Chitty-Lopez, M., Choi, G., Nicoletti, E., Long-Boyle, J., Fernandes, A., Chetty, K., De Oliveira, S., Banuelos, C., Xu-Bayford, J., Bastone, A. L., John-Neek, P., Jackson, C., …, & Kohn, D. B. (2025). Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2407376
Vancouver
Booth C, Sevilla J, Almarza E, Kuo CY, Zubicaray J, Terrazas D, et al. Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2407376
BibTeX
@article{Booth2025,
author = {Booth, Claire and Sevilla, Julián and Almarza, Elena and Kuo, Caroline Y and Zubicaray, Josune and Terrazas, Dayna and O'Toole, Gráinne and Chitty-Lopez, Maria and Choi, Grace and Nicoletti, Eileen and Long-Boyle, Janel and Fernandes, Augustine and Chetty, Kritika and De Oliveira, Satiro and Banuelos, Crystal and Xu-Bayford, Jinhua and Bastone, Antonella Lucía and John-Neek, Philipp and Jackson, Connie and Moore, Theodore B and Gilmour, Kimberly and Schambach, Axel and Rothe, Michael and Kasbekar, Sanchali and Rao, Gayatri R and Patel, Kinnari and Shah, Gaurav and Thrasher, Adrian J and Bueren, Juan A and Schwartz, Jonathan D and Kohn, Donald B},
title = {Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1},
journal = {New England Journal of Medicine},
year = {2025},
doi = {10.1056/nejmoa2407376}
}
EUVIMED